Login
News
European authorities approve Prepandrix™, a pre-pandemic vaccine for Avian Influenza virus
01 June 2008Composition of Influenza vaccine for 2008-2009 season
27 February 2008Carraguard® is safe as microbicide but does not prevent HIV transmission
18 February 2008Conferences
15th Conference on Retroviruses and Opportunistic Infections (CROI)
21st International Conference on Antiviral Research (ICAR)
18th Annual Clinical Care Options HIV Symposium
Antiviral Database
Antiviral InteliStrat has assembled the most complete and detailed Database currently available on antiviral drugs and vaccines. This Database is accessible by subscribing through one of the following options: Custom Access, Full Access and Viral Family Access.
Contact us at info@antiviralintelistrat.com for a free online DEMO!
All Full Access and Viral Family Access subscribers to the Database automatically receive free Antiviral InteliStrat's Alert Bulletin notifying them via e-mail of new antiviral drug or vaccine approval.
Note that Full Access and Viral Family Access subscription types are done on a twelve-months basis and that all indicated amounts are in US $ (prices include applicable taxes).
SEE BELOW for Database subscription rates and fees. Prices subject to changes without prior notice. REFUND POLICY
• Other ServicesOther Services
Antiviral InteliStrat also offers the following services:
- Advertisement on Antiviral InteliStrat web site and database for sponsors seeking partnership (limited to Viral Family Access and Full Access subscribers)
- Evaluation of technologies related to vaccine or antiviral drug development in the biotech and pharmaceutical industries
The cost of these particular services is variable and depends on the nature of the advertisement or the type of evaluation to be conducted. Please contact Antiviral InteliStrat to inquire about these services and their cost.